Objective: To investigate the clinical effectiveness of Arthroscopic-assisted Uni-portal Spinal Surgery (AUSS) in the treatment of lumbar spinal stenosis. Methods: A total of 475 patients with lumbar spinal stenosis from January 2019 to January 2023 were included in this study. Among them, 240 patients were treated with AUSS (AUSS group); the other 235 patients were treated with unilateral bi-portal endoscopy treatment (UBE group). The differences in surgery-related clinical indicators, pain degree before and after surgery, Oswestry Disability Index (ODI), CT imaging parameters of spinal stenosis, and clinical efficacy were compared between the two groups. Results: Patients in the AUSS group had a shorter operative time than those in the UBE group, and the length of incision and surgical bleeding were less than those in the UBE group, with statistically significant differences (P < 0.05). Before operation, there was no significant difference in the VAS score of low back pain and leg pain between the two groups (P > 0. 05). After operation, patients in both groups showed a significant reduction in low back and leg pain, and their VAS scores were significantly lower than before the operation (P < 0.05). Three months after surgery, the results of CT re-examination in both groups showed that the spinal stenosis of the patients was well improved, and the measurements of lumbar spinal interspace APDC, CAC, ICA, CAD and LAC were significantly higher than those before surgery (P < 0. 05). Besides, the lumbar function of patients improved significantly in both groups, and ODI measurements were significantly lower than those before surgery (P < 0.05). Conclusion: Both AUSS and UBE with unilateral laminotomy for bilateral decompression can achieve good clinical results in the treatment of lumbar spinal stenosis, but the former has the advantages of simpler operation, shorter operation time, shorter incision length, and less surgical blood loss.
Spinal cord ischemia-reperfusion injury (SCIRI) is a devastating condition with limited therapeutic options. This study unveils a novel role of G protein-coupled receptor 68 (GPR68), a pH-sensing G protein-coupled receptor (GPCR), in mitigating ferroptosis—a lipid peroxidation-driven cell death—through the Phosphoinositide 3-Kinase/ Protein Kinase B/ Nuclear Factor Erythroid 2-Related Factor 2 (PI3K/Akt/Nrf2) antioxidant axis. Using in vitro (Oxygen-Glucose Deprivation/Reperfusion (OGD/R)-treated Pheochromocytoma Cell Line 12 (PC12) cells ) and in vivo (rat spinal cord ischemia-reperfusion (I/R) ) models, we demonstrate that GPR68 downregulation exacerbates ferroptosis, evidenced by elevated Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4), Malondialdehyde (MDA), and Oxidized Glutathione/ Total Glutathione (GSSG/T-GSH) levels, alongside reduced Solute Carrier Family 7 Member 11 (SLC7A11) and Glutathione Peroxidase 4 (GPX4). Pharmacological activation of GPR68 with MS48107 or the clinically approved benzodiazepine Lorazepam robustly reversed ferroptosis by enhancing Akt phosphorylation and Nrf2 nuclear translocation. Mechanistically, GPR68 siRNA or PI3K/Akt inhibition abolished these protective effects. Crucially, Lorazepam rescued neuronal viability and suppressed ferroptosis in spinal I/R rats, effects fully negated by the GPR68 antagonist Ogremorphin (OGM). Our findings establish GPR68 as a key ferroptosis regulator and propose repurposing Lorazepam as a therapeutic strategy for SCIRI.
14 August 2019 in Journal of Orthopaedic Surgery and Research
The aim of this study was to evaluate the effects of different doses of ginsenoside Rb1 (GRb1) pretreatment on spinal cord ischemia-reperfusion (SCII) in rats and explore the potential mechanisms about the expression of survivin protein after the intervention. A total of 90 healthy adult Sprague-Dawley (SD) rats were randomly divided into six groups: sham-operated (n = 15), SCII model (n = 15), and GRb1-treated groups (n = 60). The GRb1-treated group was divided into four subgroups: 10 mg/kg, 20 mg/kg, 40 mg/kg, and 80 mg/kg (n = 15). The corresponding dose of GRb1 was injected intraperitoneally 30 min before operation and every day after operation. Forty-eight hours after model establishment, the neurological function of hind limbs was measured with Basso, Beattie, and Bresnahan (BBB) scale. The superoxide dismutase (SOD) and malondialdehyde (MDA) levels in serum and spinal cord tissue were detected respectively. The expression of survivin protein was observed by immunofluorescence staining. HE and TUNEL staining were used to observe neural cell injury and apoptosis, respectively, in the spinal cord of rats with SCII. The intervention of different doses of GRb1 could increase SOD activity and decrease MDA content in serum and spinal cord tissue, increase survivin protein expression, and decrease neuronal apoptosis. It was dose-dependent, but there was no significant change between 40 mg/kg and 80 mg/kg. GRb1 could reduce the cell apoptosis induced by SCII through inhibiting oxidative stress. It can also inhibit apoptosis by promoting the expression of Survivin protein. Ginsenoside Rb1 had a dose-dependent protective effect on SCII in the dose range of 10 mg/kg–40 mg/kg.
In the lumbar discectomy, an annular suture faces challenges when annular defects are located at the attachment area of the fibrous annulus at the edge of the vertebral body. In this study, a novel bone-anchoring annular suture technique was proposed to close this type of defect. Finally, the clinical efficacy of this suture technique was investigated. A total of 84 patients with lumbar intervertebral disc herniation who underwent arthroscopic-assisted uni-portal spinal surgery and novel bone-anchoring annular sutures were selected. Clinical and imaging outcomes were compared before and after surgery, including the visual analog scale (VAS) for back and leg, Japanese Orthopaedic Association (JOA) score, Oswestry disability index (ODI), disc height, and the Pfirrmann grade of the disc. The average follow-up time was 12.6 ± 0.9 months. Over time, the VAS (low back pain and leg pain) and ODI scores of patients decreased significantly (P < 0.05), while the JOA scores increased significantly (P < 0.05). At the last follow-up, the excellent and good rate was 91.7% according to the modified MacNab criteria. No significant difference between the preoperative and postoperative disc height and Pfirrmann grade was observed (P > 0.05). No reoperation cases were observed during the follow-up period. The novel bone-anchoring annular suture technique showed good safety and preliminary efficacy for annular defects that occur at the attachment area of the fibrous annulus at the edge of the vertebral body.
Degenerative lumbar spine diseases significantly affect patients’ quality of life. The far-lateral approach (FLA) in uni-portal non-coaxial spinal endoscopic surgery (UNSES) offers a minimally invasive solution for complex lesions; however, a lack of expert consensus exists regarding its use. This study aimed to establish a consensus definition for the clinical application of FLA in UNSES by aggregating expert opinions through a modified Delphi method, thereby guiding clinical decision-making. A cross-sectional modified Delphi consensus survey was conducted. Seventy-eight spine endoscopy experts were invited to complete two rounds of anonymous questionnaires. The questionnaire covered six FLA-related categories: indications, advantages, preoperative evaluation, surgical details, complications, and postoperative rehabilitation. The consensus threshold was set at ≥ 70%. The effective response rates for the two survey rounds were 94.87% and 97.44%, respectively. The expert authority coefficients were high (0.88-0.92), and Kendall's coefficients were 0.47 and 0.52, respectively. Grade A and grade B consensus were achieved for 89.5% (17/19) and 10.5% (2/19) of all items, respectively. This study demonstrates a high degree of agreement among experts on the key aspects of using FLA in UNSES. It provides a framework for standardizing surgery, optimizing patient outcomes, guiding future research, and promoting safe and effective UNSES implementation.